Patents-Review.com
ClassID:

109209 ⎘

C12N2310/50 - CPC Classification

Classification description:

Structure or type of the nucleic acid Physical structure

Sub-classes:
Recent Application in this class:
#1
20260028622
2026-01-29

RNA NANOSTRUCTURES WITH BASE MODIFICATIONS FOR REDUCING INNATE IMMUNOGENICITY

 #2
20250250567
2025-08-07

PROTOZOA TRANSCRIPTION FACTOR INHIBITOR

 #3
20250101415
2025-03-27

DNA ORIGAMI STRUCTURE AND PROTEIN NANOPORE CONSTRUCT

 #4
20250034566
2025-01-30

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

 #5
20240254486
2024-08-01

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

 #6
20240076672
2024-03-07

DOUBLE-HELIX OLIGONUCLEOTIDE CONSTRUCT COMPRISING DOUBLE-STRANDED MIRNA AND USE THEREOF

 #7
20240018519
2024-01-18

Stabilized saRNA Compositions and Methods of Use

 #8
20220403382
2022-12-22

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

 #9
20220364100
2022-11-17

OLIGONUCLEOTIDE COMPOUNDS FOR TREATMENT OF PREECLAMPSIA AND OTHER ANGIOGENIC DISORDERS

 #10
20220265838
2022-08-25

DNA-AFFIBODY-DRUG NANOPARTICLES FOR INHIBITING THE METASTASIS OF CANCER CELLS OVEREXPRESSING HER2

 #11
20220162598
2022-05-26

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

 #12
20220033813
2022-02-03

L-OLIGONUCLEOTIDE INHIBITORS OF POLYCOMB REPRESSIVE COMPLEX 2 (PRC2)

 #13
20210213136
2021-07-15

Targeting PAX2 for the treatment of breast cancer

 #14
20210171950
2021-06-10

Method of producing an aptamer and uses thereof

 #15
20210087558
2021-03-25

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

 #16
20210032628
2021-02-04

Double-helix oligonucleotide construct comprising double-stranded miRNA and use thereof

 #17
20200277610
2020-09-03

Compositions and methods for inhibiting expression of RRM2 genes

 #18
20200239879
2020-07-30

Compositions and methods for regulating proteins and nucleic acids activities

 #19
20200231973
2020-07-23

Anticancer therapeutic intervention

 #20
20200208152
2020-07-02

STABILIZED SARNA COMPOSITIONS AND METHODS OF USE

 #21
20200181614
2020-06-11

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

 #22
20200165618
2020-05-28

Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders

 #23
20200085967
2020-03-19

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #24
20200063131
2020-02-27

System and method for cell type-specific translation of RNA molecules in eukaryotes

 #25
20200056173
2020-02-20

Oligonucleotide compositions and methods thereof

 #26
20190382768
2019-12-19

Methods of using PVT1 exon 9 to diagnose and treat prostate cancer

 #27
20190367925
2019-12-05

Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor

 #28
20190352640
2019-11-21

Ribosomal RNA origami and methods preparing thereof

 #29
20190218549
2019-07-18

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

 #30
20190192687
2019-06-27

RNA/DNA HYBRID NANOPARTICLES MODIFIED WITH SINGLE STRANDED RNA TOEHOLDS AND USES THEREOF

 #31
20190177732
2019-06-13

Nucleic acid molecules inducing RNA interference, and uses thereof

 #32
20190106700
2019-04-11

siRNA And Their Use In Methods And Compositions For Inhibiting The Expression Of The ORAI1 Gene

 #33
20190060239
2019-02-28

Technology for the Preparation of Microparticles

 #34
20190048341
2019-02-14

Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA

 #35
20180228830
2018-08-16

NUCLEIC ACID COMPLEX HAVING AT LEAST ONE BULGE STRUCTURE

 #36
20180216130
2018-08-02

Nucleic acid molecules that control pathogens

 #37
20180195074
2018-07-12

Compositions and methods for inhibiting expression of RRM2 genes

 #38
20180179546
2018-06-28

Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders

 #39
20180171382
2018-06-21

BRANCHED PROXIMITY HYBRIDIZATION ASSAY

 #40
20180080029
2018-03-22

Composition for preventing or treating atopic dermatitis comprising X-shape DNA structure as active ingredient

 #41
20180080027
2018-03-22

Methods of using PVT1 exon 9 to diagnose and treat prostate cancer

 #42
20180037886
2018-02-08

Compositions and methods for inhibiting expression of the ALAS1 gene

 #43
20180028449
2018-02-01

Technology for the Preparation of Microparticles

 #44
20170362598
2017-12-21

Anticancer therapeutic intervention

 #45
20170335326
2017-11-23

Nucleic acid molecules inducing RNA interference, and uses thereof

 #46
20170298358
2017-10-19

Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor

 #47
20170260525
2017-09-14

Methods of treating, inhibiting and/or preventing an auditory impairment

 #48
20170159054
2017-06-08

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

 #49
20170137827
2017-05-18

Compositions and methods for inhibiting expression of RRM2 genes

 #50
20170130230
2017-05-11

Methods of using PVT1 exon 9 to diagnose and treat prostate cancer

 #51
20160355826
2016-12-08

Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders

 #52
20160304880
2016-10-20

SiRNA and their use in methods and compositions for inhibiting the expression of the ORAI1 gene

 #53
20160304867
2016-10-20

SiRNA and their use in methods and compositions for inhibiting the expression of the FLAP gene

 #54
20160237440
2016-08-18

siRNA and their use in methods and compositions for inhibiting the expression of the PDK1 gene

 #55
20160235675
2016-08-18

Technology for the Preparation of Microparticles

 #56
20160208280
2016-07-21

Genetic inhibition by double-stranded RNA

 #57
20160115476
2016-04-28

Compositions and methods for inhibiting expression of the ALAS1 gene

 #58
20150322431
2015-11-12

Methods and compositions of improved modified siRNA

 #59
20150259677
2015-09-17

SiRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions

 #60
20150259675
2015-09-17

Short interfering ribonucleic acid (siRNA) for oral administration

 #61
20150141266
2015-05-21

Single molecule loading methods and compositions

 #62
20150111841
2015-04-23

Compositions and methods for inhibiting expression of the ALAS1 gene

 #63
20150044196
2015-02-12

Compositions for Inhibiting Gene Expression and Uses Thereof

 #64
20150018404
2015-01-15

DOUBLE-STRANDED OLIGONUCLEOTIDE COMPOUNDS FOR TREATING HEARING AND BALANCE DISORDERS

 #65
20140350083
2014-11-27

Genetic Inhibition by Double-Stranded RNA

 #66
20140335112
2014-11-13

NOVEL DOUBLE-STRANDED RIBONUCLEIC ACIDS WITH RUGGED PHYSICO-CHEMICAL STRUCTURE AND HIGHLY SPECIFIC BIOLOGIC ACTIVITY

 #67
20140328903
2014-11-06

Means for inhibiting the expression of ANG2

 #68
20140072986
2014-03-13

Amyloid protein oligomer-binding aptamer

 #69
20130273657
2013-10-17

Nucleic acid molecules inducing RNA interference, and uses thereof

 #70
20130230492
2013-09-05

Genetic inhibition by double-stranded RNA

 #71
20130029425
2013-01-31

Genetic Inhibition by Double-Stranded RNA

 #72
20120159657
2012-06-21

Compositions and methods for inhibiting expression of RRM2 genes

 #73
20120141590
2012-06-07

Technology for the Preparation of Microparticles

 #74
20120029053
2012-02-02

Short interfering ribonucleic acid (siRNA) for oral administration

 #75
20120029052
2012-02-02

Short interfering ribonucleic acid (siRNA) for oral administration

 #76
20120022139
2012-01-26

Short interfering ribonucleic acid (siRNA) for oral administration

 #77
20120022138
2012-01-26

Means for inhibiting the expression of ANG2

 #78
20120009206
2012-01-12

Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity

 #79
20110318338
2011-12-29

Targeting PAX2 for the treatment of breast cancer

 #80
20110301229
2011-12-08

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

 #81
20110301224
2011-12-08

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #82
20110288158
2011-11-24

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

 #83
20110257384
2011-10-20

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

 #84
20110243937
2011-10-06

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #85
20110229468
2011-09-22

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #86
20110229467
2011-09-22

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #87
20110223162
2011-09-15

Targeting PAX2 for the treatment of breast cancer

 #88
20110223161
2011-09-15

Targeting PAX2 for the treatment of breast cancer

 #89
20110217299
2011-09-08

Targeting PAX2 for the treatment of breast cancer

 #90
20110212089
2011-09-01

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #91
20110206666
2011-08-25

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #92
20110206665
2011-08-25

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

 #93
20110065908
2011-03-17

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #94
20100324121
2010-12-23

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #95
20100209421
2010-08-19

Targeting PAX2 for the treatment of breast cancer

 #96
20100069465
2010-03-18

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #97
20100015707
2010-01-21

Short interfering ribonucleic acid (siRNA) with improved pharmacological properties

 #98
20100009872
2010-01-14

Single molecule loading methods and compositions

 #99
20100004436
2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #100
20100004435
2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #101
20100004434
2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #102
20100004318
2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #103
20100004317
2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #104
20100003758
2010-01-07

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #105
20090326046
2009-12-31

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #106
20090325286
2009-12-31

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #107
20090325285
2009-12-31

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #108
20090325181
2009-12-31

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #109
20090098207
2009-04-16

Technology for the Preparation of Microparticles

 #110
20090043083
2009-02-12

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #111
20090018321
2009-01-15

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

 #112
20080248576
2008-10-09

Genetic inhibition of double-stranded RNA

 #113
20080081373
2008-04-03

Genetic inhibition by double-stranded RNA

 #114
20080050342
2008-02-28

Genetic inhibition by double-stranded RNA

 #115
20050277610
2005-12-15

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

 #116
20050244858
2005-11-03

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA